<DOC>
	<DOCNO>NCT02171104</DOCNO>
	<brief_summary>This single-institution , phase II study design test ability achieve donor hematopoietic engraftment maintain low rate transplant-related mortality ( TRM ) use busulfan- fludarabine-based conditioning regimen busulfan therapeutic drug monitoring ( TDM ) patient various inherited metabolic disorder ( IMD ) severe osteopetrosis ( OP ) .</brief_summary>
	<brief_title>MT2013-31 : Allo HCT Metabolic Disorders Severe Osteopetrosis</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Mucopolysaccharidosis II</mesh_term>
	<mesh_term>Adrenoleukodystrophy</mesh_term>
	<mesh_term>Osteopetrosis</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<mesh_term>Mannosidase Deficiency Diseases</mesh_term>
	<mesh_term>alpha-Mannosidosis</mesh_term>
	<mesh_term>Leukodystrophy , Metachromatic</mesh_term>
	<mesh_term>Leukoencephalopathies</mesh_term>
	<mesh_term>Leukodystrophy , Globoid Cell</mesh_term>
	<mesh_term>Sphingolipidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis VI</mesh_term>
	<mesh_term>Mucopolysaccharidosis VII</mesh_term>
	<mesh_term>Fucosidosis</mesh_term>
	<mesh_term>Peroxisomal Disorders</mesh_term>
	<mesh_term>Refsum Disease</mesh_term>
	<mesh_term>Refsum Disease , Infantile</mesh_term>
	<mesh_term>Zellweger Syndrome</mesh_term>
	<mesh_term>Aspartylglucosaminuria</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<mesh_term>Gonadal Dysgenesis , 46 , XX</mesh_term>
	<mesh_term>Intestinal Pseudo-Obstruction</mesh_term>
	<mesh_term>Mitochondrial Encephalomyopathies</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>0 55 year age Adequate graft available Adequate organ function Eligible Diseases : 1 . Mucopolysaccharidosis Disorders ( `` IMD '' ) : 1 . MPS IH ( Hurler syndrome ) 2 . MPS II ( Hunter syndrome ) patient minimal evidence symptomatic neurologic disease expect neurologic phenotype 3 . MPS VI ( MaroteauxLamy syndrome ) 4 . MPS VII ( Sly syndrome ) 2 . Glycoprotein Metabolic Disorders ( `` IMD '' ) : 1 . Alpha mannosidosis 2 . Fucosidosis 3 . Aspartylglucosaminuria 3 . Sphingolipidoses Recessive Leukodystrophies ( `` IMD '' ) : 1 . Globoid cell leukodystrophy 2 . Metachromatic leukodystrophy 3 . NiemannPick B patient ( sphingomyelin deficiency ) 4 . NiemannPick C subtype 2 4 . Peroxisomal Disorders ( `` IMD '' ) : 1 . Adrenoleukodystrophy cerebral involvement 2 . Zellweger syndrome 3 . Neonatal Adrenoleukodystrophy 4 . Infantile Refsum disease 5 . AcylCoAOxidase Deficiency 6 . DBifunctional enzyme deficiency 7 . Multifunctional enzyme deficiency 8 . AlphamethylacylCoA Racmase Deficiency ( AMACRD ) 9 . Mitochondrial Neurogastrointestingal Encephalopathy ( MNGIE ) 5 . Severe Osteopetrosis ( OP ) 6 . Hereditary Leukoencephalopathy axonal spheroid ( HDLS ; CSF1R mutation ) 7 . Other Inherited Metabolic Disorders ( IMD ) : Patients also consider lifethreatening , rare lysosomal , peroxisomal similar inherit disorder characterize white matter disease neurologic manifestation rationale transplantation would benefit , certain patient Wolman 's disease , GM1 gangliosidosis , Icell disease , TaySachs disease , Sandhoff disease others . Any patient judgment University Minnesota Inherited Metabolic Storage Disease Group disease likely benefit allogeneic HSCT , base nature , severity state progression Prior myeloablative chemotherapy exposure within 4 month start condition protocol Uncontrolled bacterial , fungal viral infection include HIV Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>allogeneic hematopoietic cell transplantation</keyword>
	<keyword>bone marrow transplantation</keyword>
	<keyword>IMD</keyword>
	<keyword>AMACRD</keyword>
	<keyword>MNGIE</keyword>
	<keyword>HDLS</keyword>
	<keyword>OP</keyword>
	<keyword>ALD</keyword>
</DOC>